\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\:\\ pt\\ was\\ noted\\ to\\ be\\ hypoxemic\\.\\ \\(note\\:\\ further\\ h\\&p\\ records\\ unavailable\\)\ \(0\)\
\-\ labs\\:\\ \ \(3\)\
\-\ cbc\\ \\‚\\Ä\\ì\\ 10\\.0\\/16\\.1\\/48\\.6\\/201\\;\\ cmp\\ \\‚\\Ä\\ì\\ bun\\ 29\\ \\(o\\/w\\ \\~wnl\\)\ \(0\)\
\-\ afb\\ culture\\ \\‚\\Ä\\ì\\ negative\\ p\\ 6\\ wks\\;\\ mycology\\ \\‚\\Ä\\ì\\ no\\ fungal\\ growth\\ p\\ 6\\ wks\\;\\ bacteriology\\ \\(bronchial\\ washing\\)\\ \\‚\\Ä\\ì\\ few\\ gm\\ neg\\ rods\ \(0\)\
\-\ histology\\ \\‚\\Ä\\ì\\ squamous\\ cell\\ ca\\ and\\ squamous\\ cell\\ ca\\ in\\-situ\ \(0\)\
\-\ radiation\\ therapy\ \(165\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ chemotherapy\\ \\(carboplatin\\,\\ taxol\\)\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ bronchoscopy\\ repeated\\ with\\ radiologic\\ follow\\-up\\ \\(pt\\ most\\ recently\\ c\\ enlarging\\ nodules\\ at\\ site\\ of\\ treated\\ \\ \\ \\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ malignancy\\.\\)\ \(1\)\
\-\ cxr\\ \\‚\\Ä\\ì\\ increased\\ opacity\\ over\\ lower\\ t\\-spine\\ on\\ lateral\\ film\ \(0\)\
\-\ ct\\ \\‚\\Ä\\ì\\ spiculated\\ mass\\ \\(\\~2cm\\)\\ in\\ rll\\ c\\ reticular\\ stranding\\ in\\ contact\\ c\\ pleura\\;\\ no\\ chest\\ wall\\ invasion\ \(0\)\
\-\ pet\\ \\‚\\Ä\\ì\\ increased\\ radiotracer\\ uptake\\ along\\ posterior\\ aspect\\ of\\ r\\ mediastinum\\ in\\ region\\ of\\ r\\ atrium\ \(0\)\
\-\ non\\-small\\ cell\\ \\(squamous\\ cell\\)\\ carcinoma\\ of\\ the\\ lung\\ \\(rll\\)\\;\\ t3n2m0\\,\\ corresponding\\ to\\ stage\\ iii\\-a\ \(0\)\
\-\ based\\ upon\\ radiographic\\ demonstration\\ of\\ pulmonary\\ mass\\:\ \(0\)\
\-\ malignancy\\ \\(primary\\ versus\\ metastatic\\)\ \(0\)\
\-\ benign\\ neoplasm\ \(14\)\
\-\ granulomatous\\ disease\\ \\(e\\.g\\.\\,\\ tb\\,\\ fungal\\,\\ sarcoidosis\\)\ \(0\)\
\-\ other\\ inflammation\\ \\(e\\.g\\.\\,\\ pneumonia\\,\\ abscess\\)\ \(0\)\
\-\ congenital\\ abnormality\ \(6\)\
\-\ may\\ also\\ consider\\ foreign\\ body\\ or\\ mucus\\ plug\ \(0\)\
\-\ 74\\ y\\/o\\ male\\ \\(retired\\ o\\-8\\ physician\\)\\ c\\ hx\\ of\\ copd\\ and\\ s\\/p\\ cabg\\ and\\ mv\\ replacement\\ presents\\ c\\ sob\\ and\\ productive\\ cough\\.\\ \\(note\\:\\ further\\ h\\&p\\ records\\ unavailable\\)\ \(0\)\
\-\ based\\ upon\\ the\\ radiographic\\ findings\\ for\\ this\\ patient\\,\\ the\\ diagnostic\\ possibilities\\ included\\ the\\ differential\\ diagnosis\\ for\\ a\\ pulmonary\\ mass\\ \\(as\\ above\\)\\.\\ the\\ definitive\\ diagnosis\\ was\\ made\\ with\\ bronchoscopy\\ and\\ histologic\\ examination\\,\\ which\\ was\\ consistent\\ with\\ squamous\\ cell\\ carcinoma\\ of\\ the\\ lung\\.\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ the\\ american\\ cancer\\ society\\ estimated\\ over\\ 160\\,000\\ deaths\\ in\\ the\\ united\\ states\\ from\\ lung\\ cancer\\ in\\ 2004\\,\\ and\\ 87\\%\\ of\\ all\\ deaths\\ from\\ lung\\ cancer\\ are\\ attributed\\ to\\ tobacco\\ use1\\.\\ lung\\ cancer\\ is\\ generally\\ categorized\\ histologically\\ into\\ one\\ of\\ four\\ major\\ types\\ of\\ carcinoma\\:\\ adenocarcinoma\\,\\ squamous\\ cell\\,\\ large\\ cell\\,\\ and\\ small\\ cell\\.\\ the\\ former\\ three\\ are\\ distinguished\\ from\\ the\\ latter\\ as\\ non\\-small\\ cell\\ tumors\\,\\ in\\ contradistinction\\ to\\ small\\ cell\\ carcinoma\\,\\ which\\ is\\ generally\\ faster\\ growing\\ and\\ will\\ more\\ likely\\ respond\\ to\\ chemotherapy\\.\\ small\\ cell\\ carcinoma\\ only\\ accounts\\ for\\ about\\ 20\\%\\ of\\ all\\ lung\\ cancers\\,\\ while\\ the\\ remaining\\ 80\\%\\ are\\ mostly\\ non\\-small\\ cell\\ tumors\\.\\ the\\ type\\ of\\ non\\-small\\ cell\\ carcinoma\\ seen\\ in\\ this\\ patient\\,\\ squamous\\ cell\\,\\ accounts\\ for\\ 20\\-30\\%\\ of\\ all\\ lung\\ cancers\\.\\ it\\ can\\ be\\ distinguished\\ histologically\\ based\\ upon\\ keratin\\ production\\ and\\ the\\ presence\\ of\\ intercellular\\ bridges\\ as\\ seen\\ on\\ light\\ microscopy\\.\\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ in\\ terms\\ of\\ clinical\\ presentation\\,\\ cough\\ is\\ present\\ in\\ 45\\-75\\%\\ of\\ patients\\ with\\ lung\\ cancer2\\,\\ and\\ is\\ the\\ most\\ common\\ associated\\ symptom\\.\\ squamous\\ cell\\ carcinoma\\ in\\ particular\\ may\\ be\\ associated\\ with\\ elevated\\ serum\\ calcium\\ levels\\ \\(not\\ noted\\ in\\ this\\ patient\\)\\ secondary\\ to\\ production\\ of\\ a\\ parathyroid\\-like\\ hormone\\,\\ although\\ hypercalcemia\\ may\\ also\\ be\\ the\\ result\\ of\\ metastatic\\ bone\\ disease\\.\\ initial\\ workup\\ includes\\ a\\ chest\\ x\\-ray\\ with\\ two\\ views\\.\\ while\\ most\\ lesions\\,\\ even\\ those\\ less\\ than\\ 3\\ cm\\ in\\ diameter\\ \\(i\\.e\\.\\,\\ t1\\ lesions\\)\\ can\\ be\\ identified\\ with\\ radiographs\\,\\ ct\\ is\\,\\ of\\ course\\,\\ more\\ sensitive\\.\\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ imaging\\ is\\ also\\ a\\ necessary\\ tool\\ in\\ terms\\ of\\ staging\\.\\ ct\\ is\\ helpful\\ for\\ identifying\\ the\\ most\\ common\\ sites\\ of\\ metastases\\ from\\ bronchogenic\\ carcinoma\\‚\\Ä\\îspecifically\\,\\ metastatic\\ liver\\ or\\ adrenal\\ disease\\,\\ and\\ these\\ organs\\ are\\ generally\\ assessed\\ regardless\\ of\\ whether\\ or\\ not\\ the\\ patient\\ is\\ symptomatic\\.\\ other\\ imaging\\ studies\\ for\\ staging\\ are\\ generally\\ reserved\\ for\\ patients\\ whose\\ presentation\\ may\\ suggest\\ involvement\\ of\\ other\\ organs3\\,\\ such\\ as\\ the\\ brain\\ or\\ the\\ bones\\.\\ pet\\ may\\ be\\ useful\\ in\\ finding\\ metastatic\\ disease\\,\\ and\\ according\\ to\\ one\\ source\\,\\ \\‚\\Ä\\úcurrently\\,\\ the\\ accuracy\\ of\\ pet\\ in\\ the\\ detection\\ of\\ m\\ stage\\ is\\ 96\\%\\‚\\Ä\\ù\\.4\\ this\\ patient\\‚\\Ä\\ôs\\ pet\\ scan\\ revealed\\ an\\ area\\ of\\ increased\\ radiotracer\\ uptake\\ consistent\\ with\\ malignancy\\ in\\ the\\ lower\\ lobe\\ of\\ the\\ right\\ lung\\,\\ and\\ was\\ otherwise\\ normal\\.\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ treatment\\ options\\ and\\ prognosis\\ for\\ non\\-small\\ cell\\ carcinoma\\ of\\ the\\ lung\\ vary\\ depending\\ on\\ the\\ type\\ of\\ tumor\\,\\ the\\ degree\\ of\\ differentiation\\,\\ and\\ the\\ stage\\ of\\ disease\\.\\ this\\ patient\\ was\\ found\\ to\\ be\\ a\\ t3n2m0\\,\\ which\\ equates\\ to\\ a\\ stage\\ iii\\-a\\,\\ signifying\\ locally\\ advanced\\ disease\\.\\ while\\ stage\\ iii\\-a\\ is\\ technically\\ operable\\,\\ the\\ role\\ of\\ surgery\\ in\\ stage\\ iii\\ disease\\ is\\ somewhat\\ controversial\\.\\ additionally\\,\\ among\\ patients\\ with\\ non\\-small\\ cell\\ carcinoma\\ undergoing\\ surgical\\ resection\\,\\ there\\ is\\ a\\ 50\\%\\ relapse\\ rate\\.\\ treatment\\ options\\ other\\ than\\ surgery\\ include\\ radiation\\ and\\ chemotherapy\\.\\ radiation\\ therapy\\,\\ while\\ palliative\\,\\ does\\ not\\ improve\\ survival\\ over\\ the\\ long\\-term\\ for\\ most\\ patients\\ with\\ stage\\ iii\\ non\\-small\\ cell\\ lung\\ cancer\\.5\\ following\\ radiation\\ therapy\\,\\ this\\ patient\\ underwent\\ chemotherapy\\ with\\ carboplatin\\ and\\ taxol\\.\\ overall\\,\\ the\\ 5\\-year\\ survival\\ rate\\ associated\\ with\\ stage\\ iii\\-a\\ n2\\ disease\\ is\\ 10\\-15\\%\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cell\\:\\ 0\\.3235643292012948\ \(0\)\
\-\ lung\\:\\ 0\\.21026930428677065\ \(0\)\
\-\ stage\\:\\ 0\\.20019389048037026\ \(0\)\
\-\ squamous\\:\\ 0\\.19795410991164925\ \(0\)\
\-\ of\\:\\ 0\\.1967832393911518\ \(0\)\
\-\ the\\:\\ 0\\.1881049185564529\ \(0\)\
\-\ carcinoma\\:\\ 0\\.18796228559811706\ \(0\)\
\-\ iii\\:\\ 0\\.16279287922802743\ \(0\)\
\-\ small\\:\\ 0\\.1620939546421501\ \(0\)\
\-\ in\\:\\ 0\\.1407094777622278\ \(0\)\
\-\ pet\\:\\ 0\\.1164115420304189\ \(0\)\
\-\ is\\:\\ 0\\.11187266817924175\ \(0\)\
\-\ and\\:\\ 0\\.11038643931992946\ \(0\)\
\-\ generally\\:\\ 0\\.10647367222780366\ \(0\)\
\-\ disease\\:\\ 0\\.1055243758435808\ \(0\)\
\-\ cancer\\:\\ 0\\.10465198324021618\ \(0\)\
\-\ t3n2m0\\:\\ 0\\.10050662922796647\ \(0\)\
\-\ taxol\\:\\ 0\\.09286993570549001\ \(0\)\
\-\ carboplatin\\:\\ 0\\.09041146950856052\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.08925158343828175\ \(0\)\
\-\ be\\:\\ 0\\.08923133166214141\ \(0\)\
\-\ deaths\\:\\ 0\\.08670441360187325\ \(0\)\
\-\ for\\:\\ 0\\.08571850210151385\ \(0\)\
\-\ radiation\\:\\ 0\\.08329577933720946\ \(0\)\
\-\ most\\:\\ 0\\.08176918832629093\ \(0\)\
\-\ while\\:\\ 0\\.08123400631885466\ \(0\)\
\-\ records\\:\\ 0\\.0790677200793968\ \(0\)\
\-\ may\\:\\ 0\\.07906694784331814\ \(0\)\
\-\ wks\\:\\ 0\\.07759654866053714\ \(0\)\
\-\ histologically\\:\\ 0\\.07692862174730329\ \(0\)\
\-\ rll\\:\\ 0\\.07570320222457881\ \(0\)\
\-\ upon\\:\\ 0\\.07416581094598658\ \(0\)\
\-\ distinguished\\:\\ 0\\.07408801019446883\ \(0\)\
\-\ with\\:\\ 0\\.07383780649867393\ \(0\)\
\-\ patient\\:\\ 0\\.07154383249246915\ \(0\)\
\-\ terms\\:\\ 0\\.07143102655692035\ \(0\)\
\-\ patients\\:\\ 0\\.07071016738133186\ \(0\)\
\-\ to\\:\\ 0\\.07070273760919597\ \(0\)\
\-\ malignancy\\:\\ 0\\.07057466185594706\ \(0\)\
\-\ accounts\\:\\ 0\\.06995985513806069\ \(0\)\
\-\ unavailable\\:\\ 0\\.06962083085431994\ \(0\)\
\-\ metastatic\\:\\ 0\\.06893727895354768\ \(0\)\
\-\ bronchoscopy\\:\\ 0\\.06866218998023939\ \(0\)\
\-\ based\\:\\ 0\\.06828740710230272\ \(0\)\
\-\ cancers\\:\\ 0\\.0675013889411312\ \(0\)\
\-\ production\\:\\ 0\\.0675013889411312\ \(0\)\
\-\ other\\:\\ 0\\.06527529824199989\ \(0\)\
\-\ this\\:\\ 0\\.06478646609251973\ \(0\)\
\-\ staging\\:\\ 0\\.06419501064009052\ \(0\)\
\-\ survival\\:\\ 0\\.061335866837514415\ \(0\)\
\-\ are\\:\\ 0\\.059619298177129715\ \(0\)\
\-\ options\\:\\ 0\\.05666080548340448\ \(0\)\
\-\ fungal\\:\\ 0\\.05625645111487588\ \(0\)\
\-\ all\\:\\ 0\\.056117314560363014\ \(0\)\
\-\ radiotracer\\:\\ 0\\.05485997435414617\ \(0\)\
\-\ was\\:\\ 0\\.05475732812103609\ \(0\)\
\-\ therapy\\:\\ 0\\.054164836678890375\ \(0\)\
\-\ ca\\:\\ 0\\.05362075718419111\ \(0\)\
\-\ over\\:\\ 0\\.052418852562009066\ \(0\)\
\-\ increased\\:\\ 0\\.05097730524028275\ \(0\)\
\-\ as\\:\\ 0\\.05049603936133024\ \(0\)\
\-\ hypoxemic\\:\\ 0\\.05025331461398323\ \(0\)\
\-\ mycology\\:\\ 0\\.05025331461398323\ \(0\)\
\-\ use1\\:\\ 0\\.05025331461398323\ \(0\)\
\-\ cancer2\\:\\ 0\\.05025331461398323\ \(0\)\
\-\ organs3\\:\\ 0\\.05025331461398323\ \(0\)\
\-\ equates\\:\\ 0\\.05025331461398323\ \(0\)\
\-\ n2\\:\\ 0\\.05025331461398323\ \(0\)\
\-\ from\\:\\ 0\\.0499206231584912\ \(0\)\
\-\ associated\\:\\ 0\\.049687916669211796\ \(0\)\
\-\ uptake\\:\\ 0\\.04832594231700061\ \(0\)\
\-\ bacteriology\\:\\ 0\\.0480197249439088\ \(0\)\
\-\ washing\\:\\ 0\\.0480197249439088\ \(0\)\
\-\ intercellular\\:\\ 0\\.0480197249439088\ \(0\)\
\-\ bridges\\:\\ 0\\.0480197249439088\ \(0\)\
\-\ signifying\\:\\ 0\\.0480197249439088\ \(0\)\
\-\ operable\\:\\ 0\\.0480197249439088\ \(0\)\
\-\ rate\\:\\ 0\\.04762395843731632\ \(0\)\
\-\ note\\:\\ 0\\.0473110695023193\ \(0\)\
\-\ cough\\:\\ 0\\.046921414828931536\ \(0\)\
\-\ radiographic\\:\\ 0\\.0466275995535327\ \(0\)\
\-\ tumors\\:\\ 0\\.04622100655452324\ \(0\)\
\-\ pt\\:\\ 0\\.04522915064209985\ \(0\)\
\-\ faster\\:\\ 0\\.04520573475428026\ \(0\)\
\-\ also\\:\\ 0\\.04434240371386809\ \(0\)\
\-\ keratin\\:\\ 0\\.04420137818267057\ \(0\)\
\-\ or\\:\\ 0\\.04372696304601904\ \(0\)\
\-\ mv\\:\\ 0\\.04335220680093663\ \(0\)\
\-\ contradistinction\\:\\ 0\\.04335220680093663\ \(0\)\
\-\ technically\\:\\ 0\\.04335220680093663\ \(0\)\
\-\ presentation\\:\\ 0\\.04326308169871473\ \(0\)\
\-\ which\\:\\ 0\\.042865987806839236\ \(0\)\
\-\ microscopy\\:\\ 0\\.04261662109150679\ \(0\)\
\-\ type\\:\\ 0\\.042160420213383835\ \(0\)\
\-\ relapse\\:\\ 0\\.04138738799304204\ \(0\)\
\-\ further\\:\\ 0\\.04093354749275794\ \(0\)\
\-\ retired\\:\\ 0\\.04086235185847263\ \(0\)\
\-\ 20\\:\\ 0\\.040545228183273836\ \(0\)\
\-\ rods\\:\\ 0\\.039942099362300136\ \(0\)\
\-\ categorized\\:\\ 0\\.039942099362300136\ \(0\)\
\-\ tool\\:\\ 0\\.0395338600396984\ \(0\)\
\-\ society\\:\\ 0\\.03879827433026857\ \(0\)\
\-\ latter\\:\\ 0\\.03879827433026857\ \(0\)\
\-\ whose\\:\\ 0\\.03879827433026857\ \(0\)\
\-\ gm\\:\\ 0\\.038464310873651646\ \(0\)\
\-\ former\\:\\ 0\\.038464310873651646\ \(0\)\
\-\ pulmonary\\:\\ 0\\.038308370382147856\ \(0\)\
\-\ afb\\:\\ 0\\.03814944175135791\ \(0\)\
\-\ possibilities\\:\\ 0\\.03814944175135791\ \(0\)\
\-\ regardless\\:\\ 0\\.03814944175135791\ \(0\)\
\-\ assessed\\:\\ 0\\.037851601112289406\ \(0\)\
\-\ locally\\:\\ 0\\.03756904123180382\ \(0\)\
\-\ not\\:\\ 0\\.037215971035228244\ \(0\)\
\-\ cabg\\:\\ 0\\.036799133231050725\ \(0\)\
\-\ hypercalcemia\\:\\ 0\\.036799133231050725\ \(0\)\
\-\ accuracy\\:\\ 0\\.036799133231050725\ \(0\)\
\-\ respond\\:\\ 0\\.03656468466019413\ \(0\)\
\-\ reserved\\:\\ 0\\.03656468466019413\ \(0\)\
\-\ mucus\\:\\ 0\\.03612375260106192\ \(0\)\
\-\ lesions\\:\\ 0\\.036093958477476124\ \(0\)\
\-\ mass\\:\\ 0\\.0360090273849524\ \(0\)\
\-\ one\\:\\ 0\\.035983070497387255\ \(0\)\
\-\ reticular\\:\\ 0\\.03591585208128348\ \(0\)\
\-\ controversial\\:\\ 0\\.03591585208128348\ \(0\)\
\-\ ct\\:\\ 0\\.035889876689937816\ \(0\)\
\-\ demonstration\\:\\ 0\\.035715513278460176\ \(0\)\
\-\ plug\\:\\ 0\\.035715513278460176\ \(0\)\
\-\ common\\:\\ 0\\.03564165833789784\ \(0\)\
\-\ than\\:\\ 0\\.03562638817623828\ \(0\)\
\-\ vary\\:\\ 0\\.03533545156172938\ \(0\)\
\-\ histologic\\:\\ 0\\.035154821938917384\ \(0\)\
\-\ attributed\\:\\ 0\\.035154821938917384\ \(0\)\
\-\ cmp\\:\\ 0\\.034979927569030345\ \(0\)\
\-\ identifying\\:\\ 0\\.03481041542715997\ \(0\)\
\-\ more\\:\\ 0\\.03450992904367681\ \(0\)\
\-\ contact\\:\\ 0\\.03448628017999543\ \(0\)\
\-\ 87\\:\\ 0\\.03448628017999543\ \(0\)\
\-\ united\\:\\ 0\\.034331094990119694\ \(0\)\
\-\ 96\\:\\ 0\\.0341801619887506\ \(0\)\
\-\ consistent\\:\\ 0\\.034077287645305765\ \(0\)\
\-\ spiculated\\:\\ 0\\.03403325435105119\ \(0\)\
\-\ neg\\:\\ 0\\.033890162930987476\ \(0\)\
\-\ productive\\:\\ 0\\.033890162930987476\ \(0\)\
\-\ palliative\\:\\ 0\\.033890162930987476\ \(0\)\
\-\ surgery\\:\\ 0\\.03378940518931739\ \(0\)\
\-\ pleura\\:\\ 0\\.03348192360838574\ \(0\)\
\-\ copd\\:\\ 0\\.03348192360838574\ \(0\)\
\-\ histology\\:\\ 0\\.03335230092348358\ \(0\)\
\-\ tobacco\\:\\ 0\\.03335230092348358\ \(0\)\
\-\ noted\\:\\ 0\\.033321584440538836\ \(0\)\
\-\ among\\:\\ 0\\.03322565833599619\ \(0\)\
\-\ chest\\:\\ 0\\.03317402750447122\ \(0\)\
\-\ imaging\\:\\ 0\\.03302842071721883\ \(0\)\
\-\ role\\:\\ 0\\.032980786469812506\ \(0\)\
\-\ can\\:\\ 0\\.03298030963695089\ \(0\)\
\-\ mostly\\:\\ 0\\.032862315023408216\ \(0\)\
\-\ detection\\:\\ 0\\.03274633789895591\ \(0\)\
\-\ repeated\\:\\ 0\\.03263275222665179\ \(0\)\
\-\ estimated\\:\\ 0\\.03263275222665179\ \(0\)\
\-\ diagnosis\\:\\ 0\\.03257963203130429\ \(0\)\
\-\ sob\\:\\ 0\\.032521461372100845\ \(0\)\
\-\ organs\\:\\ 0\\.032412374442338986\ \(0\)\
\-\ lower\\:\\ 0\\.032115075589577775\ \(0\)\
\-\ bronchial\\:\\ 0\\.03199642523753144\ \(0\)\
\-\ symptom\\:\\ 0\\.03199642523753144\ \(0\)\
\-\ hormone\\:\\ 0\\.03199642523753144\ \(0\)\
\-\ atrium\\:\\ 0\\.03189716651722196\ \(0\)\
\-\ according\\:\\ 0\\.03160969034017013\ \(0\)\
\-\ 74\\:\\ 0\\.0312483339383113\ \(0\)\
\-\ consider\\:\\ 0\\.03090922936145483\ \(0\)\
\-\ sensitive\\:\\ 0\\.03090922936145483\ \(0\)\
\-\ growing\\:\\ 0\\.030827617351175198\ \(0\)\
\-\ whether\\:\\ 0\\.030747196799738065\ \(0\)\
\-\ particular\\:\\ 0\\.030667933418757207\ \(0\)\
\-\ sites\\:\\ 0\\.030667933418757207\ \(0\)\
\-\ differentiation\\:\\ 0\\.030512748228881472\ \(0\)\
\-\ improve\\:\\ 0\\.030512748228881472\ \(0\)\
\-\ culture\\:\\ 0\\.030436764818189136\ \(0\)\
\-\ bun\\:\\ 0\\.030287871702026407\ \(0\)\
\-\ bronchogenic\\:\\ 0\\.03021490758981297\ \(0\)\
\-\ useful\\:\\ 0\\.030001640571863563\ \(0\)\
\-\ treatment\\:\\ 0\\.029937537919088784\ \(0\)\
\-\ source\\:\\ 0\\.029932347709327373\ \(0\)\
\-\ depending\\:\\ 0\\.029932347709327373\ \(0\)\
\-\ remaining\\:\\ 0\\.029863915649970818\ \(0\)\
\-\ helpful\\:\\ 0\\.02979632326898443\ \(0\)\
\-\ 2004\\:\\ 0\\.029598384252710448\ \(0\)\
\-\ workup\\:\\ 0\\.029598384252710448\ \(0\)\
\-\ seen\\:\\ 0\\.02958803372379164\ \(0\)\
\-\ advanced\\:\\ 0\\.029533954162245364\ \(0\)\
\-\ corresponding\\:\\ 0\\.02940731157475797\ \(0\)\
\-\ enlarging\\:\\ 0\\.02934506560244883\ \(0\)\
\-\ radiologic\\:\\ 0\\.029283515130416722\ \(0\)\
\-\ types\\:\\ 0\\.029222644788015305\ \(0\)\
\-\ adrenal\\:\\ 0\\.029102885507604724\ \(0\)\
\-\ overall\\:\\ 0\\.028870905549801693\ \(0\)\
\-\ definitive\\:\\ 0\\.028703114610862623\ \(0\)\
\-\ hx\\:\\ 0\\.02859402768110076\ \(0\)\
\-\ somewhat\\:\\ 0\\.02859402768110076\ \(0\)\
\-\ undergoing\\:\\ 0\\.028540283743233752\ \(0\)\
\-\ foreign\\:\\ 0\\.02848705907858547\ \(0\)\
\-\ on\\:\\ 0\\.028471477507539252\ \(0\)\
\-\ calcium\\:\\ 0\\.02838212809767168\ \(0\)\
\-\ replacement\\:\\ 0\\.028228386679246178\ \(0\)\
\-\ serum\\:\\ 0\\.028178078476293215\ \(0\)\
\-\ stranding\\:\\ 0\\.02812822555743794\ \(0\)\
\-\ mediastinum\\:\\ 0\\.02812822555743794\ \(0\)\
\-\ invasion\\:\\ 0\\.02802985312301837\ \(0\)\
\-\ tb\\:\\ 0\\.027981317919738527\ \(0\)\
\-\ granulomatous\\:\\ 0\\.02793320661010953\ \(0\)\
\-\ versus\\:\\ 0\\.027791343578931912\ \(0\)\
\-\ prognosis\\:\\ 0\\.02765304234172381\ \(0\)\
\-\ states\\:\\ 0\\.027607702909345395\ \(0\)\
\-\ physician\\:\\ 0\\.027562733598909993\ \(0\)\
\-\ major\\:\\ 0\\.027473881512397873\ \(0\)\
\-\ degree\\:\\ 0\\.027473881512397873\ \(0\)\
\-\ recently\\:\\ 0\\.027429987177073085\ \(0\)\
\-\ 29\\:\\ 0\\.0273864398361698\ \(0\)\
\-\ opacity\\:\\ 0\\.027343234046553908\ \(0\)\
\-\ light\\:\\ 0\\.02721561343688252\ \(0\)\
\-\ included\\:\\ 0\\.027173721904683527\ \(0\)\
\-\ those\\:\\ 0\\.0268890757867419\ \(0\)\
\-\ american\\:\\ 0\\.026810378592095556\ \(0\)\
\-\ few\\:\\ 0\\.02665627875537806\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.026618418056950914\ \(0\)\
\-\ even\\:\\ 0\\.02643292208228815\ \(0\)\
\-\ necessary\\:\\ 0\\.02628889531797619\ \(0\)\
\-\ cbc\\:\\ 0\\.026218269864229978\ \(0\)\
\-\ pe\\:\\ 0\\.02597797650774621\ \(0\)\
\-\ growth\\:\\ 0\\.02591120344853375\ \(0\)\
\-\ additionally\\:\\ 0\\.025878118004112403\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.025683672761214506\ \(0\)\
\-\ suggest\\:\\ 0\\.02552671884121061\ \(0\)\
\-\ four\\:\\ 0\\.025465168369178497\ \(0\)\
\-\ metastases\\:\\ 0\\.025404298026777083\ \(0\)\
\-\ site\\:\\ 0\\.025344092947336062\ \(0\)\
\-\ bones\\:\\ 0\\.025284538746366502\ \(0\)\
\-\ inflammation\\:\\ 0\\.02525500135690282\ \(0\)\
\-\ diameter\\:\\ 0\\.02525500135690282\ \(0\)\
\-\ cxr\\:\\ 0\\.025138410551178016\ \(0\)\
\-\ nodules\\:\\ 0\\.024968024496410307\ \(0\)\
\-\ levels\\:\\ 0\\.02491238048857655\ \(0\)\
\-\ pneumonia\\:\\ 0\\.024802750802034427\ \(0\)\
\-\ views\\:\\ 0\\.024802750802034427\ \(0\)\
\-\ 80\\:\\ 0\\.024512055980464024\ \(0\)\
\-\ includes\\:\\ 0\\.02443536736463255\ \(0\)\
\-\ made\\:\\ 0\\.02423593527071375\ \(0\)\
\-\ symptomatic\\:\\ 0\\.024162971158500305\ \(0\)\
\-\ currently\\:\\ 0\\.02413886298025509\ \(0\)\
\-\ diagnostic\\:\\ 0\\.0239497041405509\ \(0\)\
\-\ about\\:\\ 0\\.023524887285315686\ \(0\)\
\-\ result\\:\\ 0\\.023524887285315686\ \(0\)\
\-\ film\\:\\ 0\\.023482017730932708\ \(0\)\
\-\ course\\:\\ 0\\.023211213759323297\ \(0\)\
\-\ studies\\:\\ 0\\.02305094907629206\ \(0\)\
\-\ abnormality\\:\\ 0\\.022856960372081826\ \(0\)\
\-\ involvement\\:\\ 0\\.022743763719228937\ \(0\)\
\-\ above\\:\\ 0\\.022669571218129406\ \(0\)\
\-\ congenital\\:\\ 0\\.02257821406733652\ \(0\)\
\-\ presence\\:\\ 0\\.02257821406733652\ \(0\)\
\-\ otherwise\\:\\ 0\\.022399923102991756\ \(0\)\
\-\ identified\\:\\ 0\\.02227846631038958\ \(0\)\
\-\ 50\\:\\ 0\\.021945512422168557\ \(0\)\
\-\ labs\\:\\ 0\\.02177061805228152\ \(0\)\
\-\ does\\:\\ 0\\.021723867758085477\ \(0\)\
\-\ liver\\:\\ 0\\.021677510879162754\ \(0\)\
\-\ underwent\\:\\ 0\\.021646821607940278\ \(0\)\
\-\ benign\\:\\ 0\\.02158595126553886\ \(0\)\
\-\ neoplasm\\:\\ 0\\.0214514034931948\ \(0\)\
\-\ elevated\\:\\ 0\\.021421945081085213\ \(0\)\
\-\ although\\:\\ 0\\.02139264336339794\ \(0\)\
\-\ less\\:\\ 0\\.02137805074576042\ \(0\)\
\-\ three\\:\\ 0\\.021094033727338327\ \(0\)\
\-\ initial\\:\\ 0\\.021080210106691918\ \(0\)\
\-\ along\\:\\ 0\\.02105266649962514\ \(0\)\
\-\ body\\:\\ 0\\.020680853414238656\ \(0\)\
\-\ finding\\:\\ 0\\.020655231461364998\ \(0\)\
\-\ revealed\\:\\ 0\\.0206043423240654\ \(0\)\
\-\ no\\:\\ 0\\.020437250147042025\ \(0\)\
\-\ differential\\:\\ 0\\.020417588509475525\ \(0\)\
\-\ radiographs\\:\\ 0\\.020380985650975486\ \(0\)\
\-\ area\\:\\ 0\\.02035671816707411\ \(0\)\
\-\ found\\:\\ 0\\.020332557119847636\ \(0\)\
\-\ aspect\\:\\ 0\\.020272614091636918\ \(0\)\
\-\ will\\:\\ 0\\.020225124918768066\ \(0\)\
\-\ such\\:\\ 0\\.02021331631845453\ \(0\)\
\-\ abscess\\:\\ 0\\.0201780416412288\ \(0\)\
\-\ resection\\:\\ 0\\.020142991406734763\ \(0\)\
\-\ examination\\:\\ 0\\.020108162776890367\ \(0\)\
\-\ clinical\\:\\ 0\\.019914854874749446\ \(0\)\
\-\ only\\:\\ 0\\.01963173632990185\ \(0\)\
\-\ brain\\:\\ 0\\.0195894427637125\ \(0\)\
\-\ t1\\:\\ 0\\.019578919914406075\ \(0\)\
\-\ treated\\:\\ 0\\.019568417127741575\ \(0\)\
\-\ negative\\:\\ 0\\.01945418907774017\ \(0\)\
\-\ primary\\:\\ 0\\.019322176807958297\ \(0\)\
\-\ wall\\:\\ 0\\.019115391298797333\ \(0\)\
\-\ following\\:\\ 0\\.018851224456891188\ \(0\)\
\-\ region\\:\\ 0\\.018796228559811702\ \(0\)\
\-\ likely\\:\\ 0\\.018778017931866123\ \(0\)\
\-\ include\\:\\ 0\\.0186968069779688\ \(0\)\
\-\ two\\:\\ 0\\.018661093984576393\ \(0\)\
\-\ scan\\:\\ 0\\.018643323937112745\ \(0\)\
\-\ secondary\\:\\ 0\\.018625611028164\ \(0\)\
\-\ lobe\\:\\ 0\\.018159569930467488\ \(0\)\
\-\ cm\\:\\ 0\\.018046979238738062\ \(0\)\
\-\ these\\:\\ 0\\.017744950421913774\ \(0\)\
\-\ bone\\:\\ 0\\.017145742407351894\ \(0\)\
\-\ into\\:\\ 0\\.016704290437885957\ \(0\)\
\-\ tumor\\:\\ 0\\.016436410880608432\ \(0\)\
\-\ posterior\\:\\ 0\\.016249458985799308\ \(0\)\
\-\ present\\:\\ 0\\.016124513816620858\ \(0\)\
\-\ it\\:\\ 0\\.016085345576891646\ \(0\)\
\-\ large\\:\\ 0\\.015744826472783392\ \(0\)\
\-\ lateral\\:\\ 0\\.015594885176627616\ \(0\)\
\-\ findings\\:\\ 0\\.015508849372750098\ \(0\)\
\-\ surgical\\:\\ 0\\.015272936359313895\ \(0\)\
\-\ presents\\:\\ 0\\.015116414914747113\ \(0\)\
\-\ male\\:\\ 0\\.013991033751140636\ \(0\)\
\-\ normal\\:\\ 0\\.012830080223902527\ \(0\)\
\-\ there\\:\\ 0\\.012503387073127536\ \(0\)\
\-\ an\\:\\ 0\\.01201631198418295\ \(0\)\
\-\ at\\:\\ 0\\.01186912395506837\ \(0\)\
\-\ right\\:\\ 0\\.010418252037153682\ \(0\)\
